Results 21 to 30 of about 235,111 (295)

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

Blood Advances, 2021
Background: Coronavirus disease 2019 (COVID-19)–related critical illness and acute illness are associated with a risk of venous thromboembolism (VTE).
A. Cuker, E. Tseng, R. Nieuwlaat, P. Angchaisuksiri, C. Blair, Kathryn E. Dane, Jennifer Davila, M. Desancho, D. Diuguid, D. Griffin, S. Kahn, F. Klok, A. Lee, I. Neumann, A. Pai, M. Pai, M. Righini, Kristen M. Sanfilippo, D. Siegal, M. Skara, Kamshad Touri, Elie A. Akl, Imad Bou Akl, M. Boulos, R. Brignardello-Petersen, R. Charide, M. Chan, K. Dearness, A. Darzi, Philipp Kolb, L. Colunga-Lozano, Razan Mansour, G. P. Morgano, R. Morsi, Atefeh Noori, Thomas Piggott, Yuan Qiu, Y. Roldán, Finn Schünemann, A. Stevens, K. Solo, M. Ventresca, W. Wiercioch, R. Mustafa, H. Schünemann   +44 more
semanticscholar   +1 more source

A re-appraisal of thrombogenesis in COVID-19, seen as a multiple "Complex system"

Bleeding, Thrombosis and Vascular Biology, 2022
The aim of this essay is to re-consider the peculiar type of thrombogenesis observed in severe cases of COVID-19 infection, focusing on the multiple interconnected networks involved, such as inflammation, blood coagulation, fibrinolysis, and immune ...
Sergio Coccheri
doaj   +1 more source

COVID-19 and its implications for thrombosis and anticoagulation

Blood, 2020
Severe acute respiratory syndrome coronavirus 2, coronavirus disease 2019 (COVID-19)-induced infection can be associated with a coagulopathy, findings consistent with infection-induced inflammatory changes as observed in patients with disseminated ...
J. Connors, J. Levy
semanticscholar   +1 more source

Descriptive analysis of patients positive for anti-phospholipid antibodies included in two Italian registries

Bleeding, Thrombosis and Vascular Biology, 2023
The definite diagnosis of antiphospholipid syndrome (APS) depends on the laboratory performance and clinicians’ interpretation. Results from two Italian inception cohort studies of anti-phospholipid antibodies (aPL)-positive subjects, the Italian Survey
Vittorio Pengo, Luca Sarti, Emilia Antonucci, Stefania Di Agostino, Elisa Bison, Gentian Denas, Daniela Poli, Pier Luigi Meroni, Roberto Gerli, Antonella Radice, Gualtiero Palareti, on behalf of FIRMA group and START collaborators   +11 more
doaj   +1 more source

Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis

medRxiv, 2021
Background: Thrombotic complications occur at high rates in hospitalized patients with COVID-19, yet the impact of intensive antithrombotic therapy on mortality is uncertain.
Matthew L. Meizlish, George Goshua, Yiwen Liu, Rebecca L. Fine, K. Amin, Eric Chang, Nicholas A. Defilippo, Craig Keating, Yuxin Liu, Michael Mankbadi, Dayna McManus, Stephen Y. Wang, C. Price, R. Bona, C. Chaar, H. Chun, A. Pine, H. Rinder, J. Siner, D. Neuberg, K. Owusu, A. Lee   +21 more
semanticscholar   +2 more sources

Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical Trial.

JAMA cardiology, 2022
Importance The optimal treatment of intermediate-high-risk pulmonary embolism (PE) remains unknown. Objective To assess the effect of conventional catheter-directed thrombolysis (cCDT) plus anticoagulation vs anticoagulation monotherapy in improving ...
P. Sadeghipour, Y. Jenab, J. Moosavi, K. Hosseini, B. Mohebbi, A. Hosseinsabet, S. Chatterjee, H. Pouraliakbar, S. Shirani, M. Shishehbor, A. Alizadehasl, M. Farrashi, Mohammad Ali Rezvani, F. Rafiee, A. Jalali, Sina Rashedi, O. Shafe, Jay S Giri, M. Monreal, D. Jiménez, I. Lang, M. Maleki, S. Goldhaber, H. Krumholz, G. Piazza, B. Bikdeli   +25 more
semanticscholar   +1 more source

Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study

British medical journal, 2021
Objective To evaluate whether early initiation of prophylactic anticoagulation compared with no anticoagulation was associated with decreased risk of death among patients admitted to hospital with coronavirus disease 2019 (covid-19) in the United States.
C. Rentsch, J. Beckman, L. Tomlinson, W. Gellad, C. Alcorn, F. Kidwai-Khan, M. Skanderson, E. Brittain, J. King, Y. Ho, Svetlana K. Eden, S. Kundu, Michael F Lann, R. Greevy, P. Ho, P. Heidenreich, D. Jacobson, I. Douglas, J. Tate, S. Evans, D. Atkins, A. Justice, M. Freiberg   +22 more
semanticscholar   +1 more source

Anticoagulation Strategies during Extracorporeal Membrane Oxygenation: A Narrative Review

Journal of Clinical Medicine, 2022
The development of extracorporeal life support technology has added a new dimension to the care of critically ill patients who fail conventional treatment options. Extracorporeal membrane oxygenation (ECMO)—specialized temporary life support for patients
Saša Rajšić, Robert Breitkopf, Dragana Jadzic, Marina Popović Krneta, H. Tauber, B. Treml   +5 more
semanticscholar   +1 more source

Thrombosis and hemostasis at the University of Padua: a reappraisal on the occasion of its 800th year of history

Bleeding, Thrombosis and Vascular Biology, 2022
The year 1222 has traditionally been accepted as the University of Padua’s founding date. The University of Padua is a prestigious center for learning and research, and over the centuries, it has produced luminaries in the most significant disciplines ...
Paolo Simioni, Vittorio Pengo, Paolo Prandoni   +2 more
doaj   +1 more source

Micronized purified flavonoid fraction for the treatment of chronic venous insufficiency, with a focus on postthrombotic syndrome: A narrative review

Research and Practice in Thrombosis and Haemostasis, 2021
Introduction Postthrombotic syndrome (PTS) is a form of secondary chronic venous insufficiency (CVI) that occurs after deep vein thrombosis (DVT). Effective treatments for PTS are lacking.
Ke Xuan Li, Gisele Diendéré, Jean‐Philippe Galanaud, Nada Mahjoub, Susan R. Kahn   +4 more
doaj   +1 more source